Rapport Therapeutics, Inc.
RAPPBiotechnology
$24.21+7.60%As of Oct 29vs prior close
- Market cap
- $1.2B
- P/E (TTM)
- –
- From 52W high
- −53.89%
- EPS (LTM)
- -$3.04
- Dividend yield
- 0.00%
Nomior Score
45
Emerging BreakoutSpeculativeBottom 38% of the scored universe
Growth—
Quality50
Value41
Momentum56
Resilience41
Connections
Revenue to profitQ1 FY26
The operating loss was 121% of revenue.
Who owns it
2funds